17-alpha-Hydroxyprogesterone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Hydroxyprogesterone caproate.
Abiraterone
The metabolism of Glimepiride can be decreased when combined with Abiraterone.
Acarbose
Acarbose may increase the hypoglycemic activities of Glimepiride.
Advertisement
Acebutolol
Acebutolol may increase the hypoglycemic activities of Glimepiride.
Acenocoumarol
Glimepiride may increase the anticoagulant activities of Acenocoumarol.
Acetohexamide
Acetohexamide may increase the hypoglycemic activities of Glimepiride.
Advertisement
Acetyl salicylate
Acetylsalicylic acid may increase the hypoglycemic activities of Glimepiride.
Albiglutide
Albiglutide may increase the hypoglycemic activities of Glimepiride.
Alogliptin
Alogliptin may increase the hypoglycemic activities of Glimepiride.
Advertisement
Aloxiprin
Aloxiprin may increase the hypoglycemic activities of Glimepiride.
Alprenolol
Alprenolol may increase the hypoglycemic activities of Glimepiride.
Aminosalicylic Acid
Aminosalicylic Acid may increase the hypoglycemic activities of Glimepiride.
Amiodarone
The metabolism of Glimepiride can be decreased when combined with Amiodarone.
Amphetamine
Amphetamine may increase the hypoglycemic activities of Glimepiride.
Anhydrous Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Glimepiride.
Anthrax immune globulin, human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Glimepiride.
Apalutamide
The serum concentration of Glimepiride can be decreased when it is combined with Apalutamide.
Aprepitant
The metabolism of Glimepiride can be increased when combined with Aprepitant.
Aripiprazole
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Aripiprazole.
Arsenic Trioxide
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Arsenic trioxide.
Articaine
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Articaine.
Asenapine
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Asenapine.
Aspirin
Acetylsalicylic acid may increase the hypoglycemic activities of Glimepiride.
Atazanavir
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Atazanavir.
Atenolol
Atenolol may increase the hypoglycemic activities of Glimepiride.
Atorvastatin
Atorvastatin may increase the hypoglycemic activities of Glimepiride.
Balsalazide
Balsalazide may increase the hypoglycemic activities of Glimepiride.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Glimepiride.
BCG, Live, Connaught Strain
The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Glimepiride.
BCG, Live, Tice Strain
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Glimepiride.
Bendroflumethiazide
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Bendroflumethiazide.
Betamethasone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Betamethasone.
Betaxolol
Betaxolol may increase the hypoglycemic activities of Glimepiride.
Bezafibrate
Bezafibrate may increase the hypoglycemic activities of Glimepiride.
Bisoprolol
Bisoprolol may increase the hypoglycemic activities of Glimepiride.
Bopindolol
Bopindolol may increase the hypoglycemic activities of Glimepiride.
Brexpiprazole
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Brexpiprazole.
Bumetanide
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Bumetanide.
Bupranolol
Bupranolol may increase the hypoglycemic activities of Glimepiride.
Buserelin
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Buserelin.
Canagliflozin
Canagliflozin may increase the hypoglycemic activities of Glimepiride.
Canagliflozin Anhydrous
Canagliflozin may increase the hypoglycemic activities of Glimepiride.
Capecitabine
The metabolism of Glimepiride can be decreased when combined with Capecitabine.
Carbamazepine
The metabolism of Glimepiride can be increased when combined with Carbamazepine.
Carbocysteine
The risk or severity of adverse effects can be increased when Glimepiride is combined with Carbocisteine.
Carteolol
Carteolol may increase the hypoglycemic activities of Glimepiride.
Carvedilol
Carvedilol may increase the hypoglycemic activities of Glimepiride.
Celiprolol
Celiprolol may increase the hypoglycemic activities of Glimepiride.
Ceritinib
The serum concentration of Glimepiride can be increased when it is combined with Ceritinib.
Chloramphenicol
The metabolism of Glimepiride can be decreased when combined with Chloramphenicol.
Chlorothiazide
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Chlorothiazide.
Chlorpropamide
Glimepiride may increase the hypoglycemic activities of Chlorpropamide.
Chlorthalidone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Chlorthalidone.
Cholecalciferol
The metabolism of Glimepiride can be decreased when combined with Cholecalciferol.
Cimetidine
The serum concentration of Glimepiride can be increased when it is combined with Cimetidine.
Cinoxacin
Cinoxacin may increase the hypoglycemic activities of Glimepiride.
Ciprofibrate
Ciprofibrate may increase the hypoglycemic activities of Glimepiride.
Citalopram
Citalopram may increase the hypoglycemic activities of Glimepiride.
Clofibrate
Clofibrate may increase the hypoglycemic activities of Glimepiride.
Clotrimazole
The metabolism of Glimepiride can be decreased when combined with Clotrimazole.
Clozapine
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Clozapine.
coenzyme Q10
The therapeutic efficacy of Glimepiride can be increased when used in combination with Ubidecarenone.
Colesevelam
The serum concentration of Glimepiride can be decreased when it is combined with Colesevelam.
Corticotropin
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Corticotropin.
Cortisone Acetate
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Cortisone acetate.
Crisaborole
The metabolism of Glimepiride can be decreased when combined with Crisaborole.
Cyclopenthiazide
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Cyclopenthiazide.
Cyclosporine
The metabolism of Glimepiride can be decreased when combined with Cyclosporine.
Cyproterone Acetate
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Cyproterone acetate.
Dabrafenib
The serum concentration of Glimepiride can be decreased when it is combined with Dabrafenib.
Danazol
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Danazol.
Darunavir
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Darunavir.
Delavirdine
The metabolism of Glimepiride can be decreased when combined with Delavirdine.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Glimepiride.
Desogestrel
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Desogestrel.
Desvenlafaxine
Desvenlafaxine may increase the hypoglycemic activities of Glimepiride.
Dexamethasone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Dexamethasone.
Diazoxide
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Diazoxide.
Dicumarol
Glimepiride may increase the anticoagulant activities of Dicoumarol.
Dienogest
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Dienogest.
Diflunisal
Diflunisal may increase the hypoglycemic activities of Glimepiride.
Disopyramide
Glimepiride may increase the hypoglycemic activities of Disopyramide.
Dothiepin
The metabolism of Glimepiride can be decreased when combined with Dosulepin.
Drospirenone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Drospirenone.
Dulaglutide
Dulaglutide may increase the hypoglycemic activities of Glimepiride.
Duloxetine
Duloxetine may increase the hypoglycemic activities of Glimepiride.
Efavirenz
The metabolism of Glimepiride can be decreased when combined with Efavirenz.
Empagliflozin
Empagliflozin may increase the hypoglycemic activities of Glimepiride.
Enoxacin
Enoxacin may increase the hypoglycemic activities of Glimepiride.
Epinephrine
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Epinephrine.
Ertugliflozin
Ertugliflozin may increase the hypoglycemic activities of Glimepiride.
Escitalopram
Escitalopram may increase the hypoglycemic activities of Glimepiride.
Esmolol
Esmolol may increase the hypoglycemic activities of Glimepiride.
Estradiol
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Estradiol.
Ethacrynate
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Etacrynic acid.
Ethacrynic Acid
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Etacrynic acid.
Ethanol
The risk or severity of adverse effects can be increased when Glimepiride is combined with Ethanol.
Ethinyl Estradiol
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Ethinyl Estradiol.
Ethynodiol Diacetate
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Ethynodiol diacetate.
Etofibrate
Etofibrate may increase the hypoglycemic activities of Glimepiride.
Etonogestrel
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Etonogestrel.
Etravirine
The metabolism of Glimepiride can be decreased when combined with Etravirine.
Everolimus
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Everolimus.
Exenatide
Exenatide may increase the hypoglycemic activities of Glimepiride.
Fenofibrate
Fenofibrate may increase the hypoglycemic activities of Glimepiride.
Fenofibric Acid
Fenofibric acid may increase the hypoglycemic activities of Glimepiride.
Fingolimod
Glimepiride may increase the immunosuppressive activities of Fingolimod.
Fleroxacin
Fleroxacin may increase the hypoglycemic activities of Glimepiride.
Floxuridine
The metabolism of Glimepiride can be decreased when combined with Floxuridine.
Fluconazole
The serum concentration of Glimepiride can be increased when it is combined with Fluconazole.
Fludrocortisone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Fludrocortisone.
Fluindione
Glimepiride may increase the anticoagulant activities of Fluindione.
Flumequine
Flumequine may increase the hypoglycemic activities of Glimepiride.
Fluorouracil
The metabolism of Glimepiride can be decreased when combined with Fluorouracil.
Fluoxetine
Fluoxetine may increase the hypoglycemic activities of Glimepiride.
Fluoxymesterone
Fluoxymesterone may increase the hypoglycemic activities of Glimepiride.
Fluvastatin
The metabolism of Glimepiride can be decreased when combined with Fluvastatin.
Fluvoxamine
The metabolism of Glimepiride can be decreased when combined with Fluvoxamine.
Fosamprenavir
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Fosamprenavir.
Fosphenytoin
The metabolism of Glimepiride can be increased when combined with Fosphenytoin.
Furazolidone
Furazolidone may increase the hypoglycemic activities of Glimepiride.
Furosemide
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Furosemide.
Gatifloxacin
Gatifloxacin may increase the hypoglycemic activities of Glimepiride.
Gatifloxacin Anhydrous
Gatifloxacin may increase the hypoglycemic activities of Glimepiride.
Gemfibrozil
The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.
Gemifloxacin
Gemifloxacin may increase the hypoglycemic activities of Glimepiride.
Gemifloxacin Mesylate
Gemifloxacin may increase the hypoglycemic activities of Glimepiride.
Glibornuride
Glibornuride may increase the hypoglycemic activities of Glimepiride.
Gliclazide
Glimepiride may increase the hypoglycemic activities of Gliclazide.
Glipizide
Glimepiride may increase the hypoglycemic activities of Glipizide.
Gliquidone
Gliquidone may increase the hypoglycemic activities of Glimepiride.
Glyburide
Glimepiride may increase the hypoglycemic activities of Glyburide.
Goserelin
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Goserelin.
Grepafloxacin
Grepafloxacin may increase the hypoglycemic activities of Glimepiride.
Hepatitis A Vaccine, Inactivated
The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Glimepiride.
Hepatitis B Surface Antigen Vaccine
The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Glimepiride.
Histrelin
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Histrelin.
Hydrochlorothiazide
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Hydrochlorothiazide.
Hydrocortisone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Hydroflumethiazide.
hydroxyprogesterone caproate (USP)
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Hydroxyprogesterone caproate.
Iloperidone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Iloperidone.
Indapamide
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Indapamide.
Indinavir
The metabolism of Glimepiride can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Glimepiride can be decreased when combined with Indinavir.
Insulin Detemir
Glimepiride may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Insulin Glargine may increase the hypoglycemic activities of Glimepiride.
insulin human, rDNA origin
Insulin Human may increase the hypoglycemic activities of Glimepiride.
Insulin Lispro
Insulin Lispro may increase the hypoglycemic activities of Glimepiride.
Insulin, Aspart Protamine, Human
Glimepiride may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Glimepiride may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Glimepiride may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Pork
Insulin Pork may increase the hypoglycemic activities of Glimepiride.
Insulin, Protamine Lispro, Human
Insulin Lispro may increase the hypoglycemic activities of Glimepiride.
Insulin, Regular, Pork
Insulin Pork may increase the hypoglycemic activities of Glimepiride.
Iproniazid
Iproniazid may increase the hypoglycemic activities of Glimepiride.
Irbesartan
The metabolism of Glimepiride can be decreased when combined with Irbesartan.
Isocarboxazid
Isocarboxazid may increase the hypoglycemic activities of Glimepiride.
Ketoconazole
The metabolism of Glimepiride can be decreased when combined with Ketoconazole.
Labetalol
Labetalol may increase the hypoglycemic activities of Glimepiride.
Lanreotide
Glimepiride may increase the hypoglycemic activities of Lanreotide.
Leflunomide
The risk or severity of adverse effects can be increased when Glimepiride is combined with Leflunomide.
Leuprolide
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Leuprolide.
Levobunolol
Levobunolol may increase the hypoglycemic activities of Glimepiride.
Levofloxacin
Levofloxacin may increase the hypoglycemic activities of Glimepiride.
Levofloxacin Anhydrous
Levofloxacin may increase the hypoglycemic activities of Glimepiride.
Levomilnacipran
Levomilnacipran may increase the hypoglycemic activities of Glimepiride.
Levonorgestrel
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Levonorgestrel.
Linagliptin
Linagliptin may increase the hypoglycemic activities of Glimepiride.
Liraglutide
Liraglutide may increase the hypoglycemic activities of Glimepiride.
Lopinavir
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Lopinavir.
Losartan
The metabolism of Glimepiride can be decreased when combined with Losartan.
Lovastatin
The metabolism of Glimepiride can be decreased when combined with Lovastatin.
Lumacaftor
The serum concentration of Glimepiride can be decreased when it is combined with Lumacaftor.
Lurasidone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Lurasidone.
Manidipine
The metabolism of Glimepiride can be decreased when combined with Manidipine.
Mecasermin
Glimepiride may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Glimepiride may increase the hypoglycemic activities of Mecasermin.
Medrogestone
The serum concentration of Glimepiride can be decreased when it is combined with Medrogestone.
Medroxyprogesterone Acetate
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Medroxyprogesterone acetate.
Megestrol Acetate
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Megestrol acetate.
Mesalamine
Mesalazine may increase the hypoglycemic activities of Glimepiride.
Mesterolone
Mesterolone may increase the hypoglycemic activities of Glimepiride.
Mestranol
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Mestranol.
Metformin
Metformin may increase the hypoglycemic activities of Glimepiride.
Methotrimeprazine
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Methotrimeprazine.
Methyclothiazide
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Methyclothiazide.
Methyl Salicylate
Methyl salicylate may increase the hypoglycemic activities of Glimepiride.
Methylene blue
Methylene blue may increase the hypoglycemic activities of Glimepiride.
Methylprednisolone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Methylprednisolone.
Methyltestosterone
Methyltestosterone may increase the hypoglycemic activities of Glimepiride.
Metipranolol
Metipranolol may increase the hypoglycemic activities of Glimepiride.
Metolazone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Metolazone.
Metoprolol
Metoprolol may increase the hypoglycemic activities of Glimepiride.
Metreleptin
Metreleptin may increase the hypoglycemic activities of Glimepiride.
Miconazole
Miconazole may increase the hypoglycemic activities of Glimepiride.
Midostaurin
The metabolism of Glimepiride can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Glimepiride can be increased when it is combined with Mifepristone.
Miglitol
Miglitol may increase the hypoglycemic activities of Glimepiride.
Miglustat
Miglustat may increase the hypoglycemic activities of Glimepiride.
Milnacipran
Milnacipran may increase the hypoglycemic activities of Glimepiride.
Minaprine
Minaprine may increase the hypoglycemic activities of Glimepiride.
Moclobemide
Moclobemide may increase the hypoglycemic activities of Glimepiride.
Nadolol
Nadolol may increase the hypoglycemic activities of Glimepiride.
Nalidixic Acid
Nalidixic Acid may increase the hypoglycemic activities of Glimepiride.
Nandrolone
Nandrolone may increase the hypoglycemic activities of Glimepiride.
Nandrolone Decanoate
Nandrolone decanoate may increase the hypoglycemic activities of Glimepiride.
Natalizumab
The risk or severity of adverse effects can be increased when Glimepiride is combined with Natalizumab.
Nateglinide
Glimepiride may increase the hypoglycemic activities of Nateglinide.
Nebivolol
Nebivolol may increase the hypoglycemic activities of Glimepiride.
Nefazodone
Nefazodone may increase the hypoglycemic activities of Glimepiride.
Nelfinavir
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Nelfinavir.
Niacin
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Niacin.
Nialamide
Nialamide may increase the hypoglycemic activities of Glimepiride.
Nicardipine
The metabolism of Glimepiride can be decreased when combined with Nicardipine.
Nilotinib
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Nilotinib.
Norethindrone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Norethisterone.
Norfloxacin
Norfloxacin may increase the hypoglycemic activities of Glimepiride.
Norgestimate
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Norgestimate.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Glimepiride.
Octreotide
Octreotide may increase the hypoglycemic activities of Glimepiride.
Olanzapine
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Olanzapine.
Olsalazine
Olsalazine may increase the hypoglycemic activities of Glimepiride.
Omeprazole
The metabolism of Glimepiride can be decreased when combined with Omeprazole.
Oxandrolone
Oxandrolone may increase the hypoglycemic activities of Glimepiride.
Oxprenolol
Oxprenolol may increase the hypoglycemic activities of Glimepiride.
Oxymetholone
Oxymetholone may increase the hypoglycemic activities of Glimepiride.
Paliperidone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Paliperidone.
Pargyline
Pargyline may increase the hypoglycemic activities of Glimepiride.
Paroxetine
Paroxetine may increase the hypoglycemic activities of Glimepiride.
Pasireotide
Glimepiride may increase the hypoglycemic activities of Pasireotide.
Pefloxacin
Pefloxacin may increase the hypoglycemic activities of Glimepiride.
Pegvisomant
Pegvisomant may increase the hypoglycemic activities of Glimepiride.
Penbutolol
Penbutolol may increase the hypoglycemic activities of Glimepiride.
Pentamidine
Glimepiride may increase the hypoglycemic activities of Pentamidine.
Phenelzine
Phenelzine may increase the hypoglycemic activities of Glimepiride.
Phenformin
Phenformin may increase the hypoglycemic activities of Glimepiride.
Phenindione
Glimepiride may increase the anticoagulant activities of Phenindione.
Phenobarbital
The metabolism of Glimepiride can be increased when combined with Phenobarbital.
Phenprocoumon
Glimepiride may increase the anticoagulant activities of Phenprocoumon.
Phenytoin
The metabolism of Glimepiride can be increased when combined with Phenytoin.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Glimepiride.
Pindolol
Pindolol may increase the hypoglycemic activities of Glimepiride.
Pioglitazone
Pioglitazone may increase the hypoglycemic activities of Glimepiride.
Piperazine
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Piperazine.
Pipothiazine
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Pipotiazine.
Polythiazide
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Polythiazide.
Practolol
Practolol may increase the hypoglycemic activities of Glimepiride.
Pramlintide
Pramlintide may increase the hypoglycemic activities of Glimepiride.
Prednisolone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Prednisolone.
Prednisone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Prednisone.
Pregabalin
The risk or severity of heart failure can be increased when Pregabalin is combined with Glimepiride.
Primidone
The metabolism of Glimepiride can be increased when combined with Primidone.
Probenecid
The protein binding of Glimepiride can be decreased when combined with Probenecid.
Procarbazine
Procarbazine may increase the hypoglycemic activities of Glimepiride.
Progesterone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Progesterone.
Propranolol
Propranolol may increase the hypoglycemic activities of Glimepiride.
Pyrimethamine
The metabolism of Glimepiride can be decreased when combined with Pyrimethamine.
Quetiapine
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Quetiapine.
Quetiapine fumarate
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Quetiapine.
Quinethazone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Quinethazone.
Quinine
The metabolism of Glimepiride can be decreased when combined with Quinine.
Rabies Immune Globulin, Human
The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Glimepiride.
Rabies Virus Vaccine Flury-Lep Strain
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Glimepiride.
Ranitidine
The serum concentration of Glimepiride can be increased when it is combined with Ranitidine.
Rasagiline
Rasagiline may increase the hypoglycemic activities of Glimepiride.
Regular Insulin, Human
Insulin Human may increase the hypoglycemic activities of Glimepiride.
Repaglinide
Glimepiride may increase the hypoglycemic activities of Repaglinide.
Rifampin
The serum concentration of Glimepiride can be decreased when it is combined with Rifampicin.
Rifapentine
The metabolism of Glimepiride can be increased when combined with Rifapentine.
Risperidone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Risperidone.
Ritonavir
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Ritonavir.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Glimepiride.
Rosiglitazone
Rosiglitazone may increase the hypoglycemic activities of Glimepiride.
Rosoxacin
Rosoxacin may increase the hypoglycemic activities of Glimepiride.
ROTAVIRUS VACCINE, LIVE
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Glimepiride.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Glimepiride.
Rucaparib
The metabolism of Glimepiride can be decreased when combined with Rucaparib.
Salicylic Acid
Salicylic acid may increase the hypoglycemic activities of Glimepiride.
Salmonella enterica subsp. enterica serovar typhi
The therapeutic efficacy of Salmonella typhi ty21a live antigen can be decreased when used in combination with Glimepiride.
Saquinavir
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Saquinavir.
Saquinavir Mesylate
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Saquinavir.
Saxagliptin
Saxagliptin may increase the hypoglycemic activities of Glimepiride.
Saxagliptin Anhydrous
Saxagliptin may increase the hypoglycemic activities of Glimepiride.
Secobarbital
The metabolism of Glimepiride can be increased when combined with Secobarbital.
Selegiline
Selegiline may increase the hypoglycemic activities of Glimepiride.
Sertraline
Sertraline may increase the hypoglycemic activities of Glimepiride.
Sildenafil
The metabolism of Glimepiride can be decreased when combined with Sildenafil.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Glimepiride.
Sirolimus
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Sirolimus.
Sitagliptin
Sitagliptin may increase the hypoglycemic activities of Glimepiride.
Sitagliptin Phosphate
Sitagliptin may increase the hypoglycemic activities of Glimepiride.
Sorafenib
The metabolism of Glimepiride can be decreased when combined with Sorafenib.
Sotalol
Sotalol may increase the hypoglycemic activities of Glimepiride.
Sparfloxacin
Sparfloxacin may increase the hypoglycemic activities of Glimepiride.
Stanozolol
Stanozolol may increase the hypoglycemic activities of Glimepiride.
Sulfadiazine
The metabolism of Glimepiride can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Glimepiride can be decreased when combined with Sulfamethoxazole.
Sulfisoxazole
The metabolism of Glimepiride can be decreased when combined with Sulfisoxazole.
Sunitinib
Glimepiride may increase the hypoglycemic activities of Sunitinib.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Glimepiride.
Talinolol
Talinolol may increase the hypoglycemic activities of Glimepiride.
Temafloxacin
Temafloxacin may increase the hypoglycemic activities of Glimepiride.
Temsirolimus
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Temsirolimus.
Testosterone
Testosterone may increase the hypoglycemic activities of Glimepiride.
Testosterone Cypionate
Testosterone cypionate may increase the hypoglycemic activities of Glimepiride.
Testosterone Enanthate
Testosterone enanthate may increase the hypoglycemic activities of Glimepiride.
Testosterone Propionate
Testosterone propionate may increase the hypoglycemic activities of Glimepiride.
Testosterone Undecanoate
Testosterone undecanoate may increase the hypoglycemic activities of Glimepiride.
Tetanus Toxoid Vaccine, Inactivated
The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Glimepiride.
Thioctic Acid
Lipoic Acid may increase the hypoglycemic activities of Glimepiride.
Ticagrelor
The metabolism of Glimepiride can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Glimepiride can be decreased when combined with Ticlopidine.
Timolol
Timolol may increase the hypoglycemic activities of Glimepiride.
Timolol Anhydrous
Timolol may increase the hypoglycemic activities of Glimepiride.
Tipranavir
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Tipranavir.
Tofacitinib
Glimepiride may increase the immunosuppressive activities of Tofacitinib.
Tolazamide
Glimepiride may increase the hypoglycemic activities of Tolazamide.
Tolbutamide
The metabolism of Glimepiride can be decreased when combined with Tolbutamide.
Toloxatone
Toloxatone may increase the hypoglycemic activities of Glimepiride.
Torsemide
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Torasemide.
Tranylcypromine
Tranylcypromine may increase the hypoglycemic activities of Glimepiride.
Trastuzumab
Trastuzumab may increase the neutropenic activities of Glimepiride.
Triamcinolone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Triamcinolone.
Trichlormethiazide
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Trichlormethiazide.
Trimethoprim
The metabolism of Glimepiride can be decreased when combined with Trimethoprim.
Triptorelin
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Triptorelin.
Troglitazone
Troglitazone may increase the hypoglycemic activities of Glimepiride.
Trolamine Salicylate
Trolamine salicylate may increase the hypoglycemic activities of Glimepiride.
Trovafloxacin
Trovafloxacin may increase the hypoglycemic activities of Glimepiride.
Typhoid Vaccine Live Ty21a
The therapeutic efficacy of Salmonella typhi ty21a live antigen can be decreased when used in combination with Glimepiride.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The therapeutic efficacy of Salmonella typhi ty2 vi polysaccharide antigen can be decreased when used in combination with Glimepiride.
Valproate
The metabolism of Glimepiride can be decreased when combined with Valproic Acid.
Valproic Acid
The metabolism of Glimepiride can be decreased when combined with Valproic Acid.
Valsartan
The metabolism of Glimepiride can be decreased when combined with Valsartan.
Varicella Virus Vaccine Live (Oka-Merck) strain
The therapeutic efficacy of Varicella Zoster Vaccine (Live/Attenuated) can be decreased when used in combination with Glimepiride.
Venlafaxine
Venlafaxine may increase the hypoglycemic activities of Glimepiride.
Vildagliptin
Vildagliptin may increase the hypoglycemic activities of Glimepiride.
Voriconazole
The serum concentration of Glimepiride can be increased when it is combined with Voriconazole.
Vorinostat
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Vorinostat.
Warfarin
Glimepiride may increase the anticoagulant activities of Warfarin.
Yellow Fever Vaccine
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Glimepiride.
Yellow-Fever Virus Vaccine, 17D-204 strain
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Glimepiride.
Zafirlukast
The metabolism of Glimepiride can be decreased when combined with Zafirlukast.
Ziprasidone
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Ziprasidone.
